The DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents [1] (multiple letters)

New England Journal of Medicine

Volumn 344, Issue 9, 2001, Pages 686-688

  Buckner, Jan C ^a   Moynihan, Timothy J ^a   Quinn, David I ^b   Schlegel, Uwe ^c   Ali Osman, Francis ^d   Srivenugopal, Kalkunte ^d   Sawaya, Raymond ^d   Esteller, Manel ^e   Herman, James G ^e   Weinstein, John N ^f  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY HOSPITAL BONN   (Germany)

^d UNIVERSITY OF TEXAS   (United States)

^e JOHNS HOPKINS UNIVERSITY   (United States)

^f NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; CARMUSTINE; CISPLATIN; DNA; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; NIMUSTINE;

AGE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; DNA ALKYLATION; DNA REPAIR; GLIOMA; HUMAN; LETTER; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; TUMOR VOLUME; AGE DISTRIBUTION; DNA METHYLATION; GENETICS; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; NOTE; ADULT; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY;

AGE DISTRIBUTION; ANTINEOPLASTIC AGENTS, ALKYLATING; CARMUSTINE; COMBINED MODALITY THERAPY; DNA METHYLATION; DNA, NEOPLASM; GLIOMA; HUMANS; MIDDLE AGED; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; PROMOTER REGIONS (GENETICS); ADULT; PROGNOSIS; MAGNETIC RESONANCE IMAGING;

EID: 0035282722     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200103013440914     Document Type: Letter

References (0)